ΒΙΒΛΙΟΓΡΑΦΙΑ
1. Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020). How will country-based mitigation measures influence the course of the COVID- 19 epidemic? The Lancet, 395(10228), 931- 934.
2. Bonanno, G. A. (2004). Loss, trauma, and human resilience – have we under- estimated the human capacity to thrive after extremely aversive events? American Psychologist, 59(1), 20–28. doi:10.1037/0003-066x.59.1.20.
3. Center for Disease Control and Prevention (CDC).
4. Craine, S. (1998). The survivor movement and the survivor perspective, Shrink Resistance: US Network Working Papers, 3, 1-21.
5. Current Diagnosis & Treatment: Geriatrics, 2nd ed, Chen, 2014: 16-17. [VitalSource Bookshelf version]. McGraw-Hill Create. Retrieved from vbk://9781308900797.
6. «Getting your workplace ready for COVID-19» (PDF). World Health Organization. 27 Φεβρουαρίου 2020.
7. Goyal, K., Chauhan, P., Chhikara, K., Gupta, P., & Singh, M. P. (2020). Fear of COVID 2019: First suicidal case in India. Asian Journal of Psychiatry, 49, e101989.
8. Haider, N., Osman, A. Y., Gadzekpo, A., Akipede, G. O., Asogun, D., Ansumana, R., ... McCoy, D. (2020). Lockdown measures in response to COVID-19 in nine sub-Saharan African countries. BMJ Global Health, 5(10), e003319. doi:10.1136/bmjgh-2020-003319.
9. Harper, C.A., Satchell, L. P., Fido, D., & Latzman, R.D. (2020). Functional fear predicts public health compliance in the COVID-19 pandemic. PsyArXiv Preprints. doi: 10.31234/osf.io/jkfu3.
10. Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; published online, April 15. DOI:10.1056/NEJMc2008597.
11. Hoog, N., Stroebe, W., & de Wit, J. B. (2008). The processing of fear‐arousing communications: How biased processing leads to persuasion. Social Influence, 3(2), 84-113.
12. Hopkins RO, Weaver LK, Pope D, Orme JF Jr, Bigler ED, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160: 50–56.
13. Keyes, C. L. M. (2005). Mental illness and/or mental health? Investigating axioms of the complete state model of health. Journal of Consulting and Clinical Psychology, 73(3), 539–548. Doi:10.1037/0022-006x.73.3.539.
14. Lipsitch, M., Swerdlow, D. L., & Finelli, L. (2020). Defining the epidemiology of Covid- 19 – Studies needed. New England Journal of Medicine, 382, 1194-1196.
15. Mamun, M.A. & Griffiths, M.D. (2020). First COVID-19 suicide case in Bangladesh due to fear of COVID-19 and xenophobia: Possible suicide prevention strategies. Asian Journal of Psychiatry, in press.
16. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395: 1033–34.
17. Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., ... David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry, 7(7), 611–627. doi:10.1016/S2215-0366(20)30203-0.
18. Siu JY. The SARS-associated stigma of SARS victims in the post- SARS era of Hong Kong. Qual Health Res 2008; 18: 729–38.
19. Tannenbaum, M. B., Hepler, J., Zimmerman, R. S., Saul, L., Jacobs, S., Wilson, K., & Albarracín, D. (2015). Appealing to fear: A meta-analysis of fear appeal effectiveness and theories. Psychological Bulletin, 141(6), 1178-1204.
20. Wohleb ES, Franklin T, Iwata M, Duman RS. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci 2016; 17: 497–511.
21. Η ελεύθερη εγκυκλοπαιδεία - ΒΙΚΙΠΑΙΔΕΙΑ.